Capstone Investment Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-147,600
Closed -$1.02M 1836
2021
Q1
$1.02M Buy
147,600
+53,100
+56% +$449K ﹤0.01% 1109
2020
Q4
$964K Buy
+94,500
New +$613K ﹤0.01% 1093
2020
Q2
Sell
-30,200
Closed -$103K 1357
2020
Q1
$103K Sell
30,200
-20,000
-40% -$86.3K ﹤0.01% 1061
2019
Q4
$275K Buy
+50,200
New +$283K ﹤0.01% 1223

Other funds holding PGEN

Capstone Investment Advisors's PGEN Position: Q2 2021 in Review

Capstone Investment Advisors sold out of Precigen (PGEN) in Q2 2021, closing a stake of 120,341 shares — an estimated $829K sold.

Capstone Investment Advisors first reported a position in PGEN in Q4 2015 and held it in 8 quarters. The position peaked at $1.32M in Q4 2020. 150 funds tracked by Wall St. Rank hold PGEN as of Q2 2021.

  • Capstone Investment Advisors reported no remaining Precigen position as of Q2 2021 after selling out during the quarter.
  • Capstone Investment Advisors sold 120,341 Precigen shares in Q2 2021, an estimated $829K.
  • Capstone Investment Advisors first reported a position in Precigen in Q4 2015 and held it in 8 quarters.
  • Capstone Investment Advisors's Precigen position peaked at $1.32M in Q4 2020.
  • 150 funds tracked by Wall St. Rank held Precigen as of Q2 2021.

Based on Capstone Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.